Andra AP-fonden’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-198,700
| Closed | -$5.58M | – | 428 |
|
|
2023
Q4 | $5.58M | Buy |
198,700
+40,500
| +26% | +$1.14M | 0.3% | 158 |
|
|
2023
Q3 | $4.29M | Buy |
158,200
+5,500
| +4% | +$149K | 0.25% | 192 |
|
|
2023
Q2 | $4.69M | Buy |
152,700
+42,100
| +38% | +$1.29M | 0.12% | 405 |
|
|
2023
Q1 | $3.98M | Sell |
110,600
-41,200
| -27% | -$1.48M | 0.1% | 422 |
|
|
2022
Q4 | $6M | Sell |
151,800
-18,400
| -11% | -$727K | 0.18% | 251 |
|
|
2022
Q3 | $6.84M | Buy |
170,200
+30,900
| +22% | +$1.24M | 0.22% | 175 |
|
|
2022
Q2 | $5.86M | Buy |
+139,300
| New | +$5.86M | 0.17% | 272 |
|
|
2021
Q4 | $5.67M | Sell |
142,300
-16,300
| -10% | -$650K | 0.12% | 391 |
|
|
2021
Q3 | $5.73M | Buy |
158,600
+28,500
| +22% | +$1.03M | 0.12% | 389 |
|
|
2021
Q2 | $5.33M | Buy |
130,100
+29,800
| +30% | +$1.22M | 0.11% | 426 |
|
|
2021
Q1 | $4.38M | Sell |
100,300
-16,500
| -14% | -$720K | 0.1% | 459 |
|
|
2020
Q4 | $5.85M | Buy |
+116,800
| New | +$5.85M | 0.13% | 392 |
|